Boston Financial Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $219K | Hold |
3,197
| – | – | 0.01% | 317 |
|
|
2024
Q3 | $230K | Hold |
3,197
| – | – | 0.01% | 304 |
|
|
2024
Q2 | $222K | Hold |
3,197
| – | – | 0.01% | 312 |
|
|
2024
Q1 | $256K | Hold |
3,197
| – | – | 0.01% | 300 |
|
|
2023
Q4 | $350K | Hold |
3,197
| – | – | 0.01% | 270 |
|
|
2023
Q3 | $322K | Hold |
3,197
| – | – | 0.01% | 259 |
|
|
2023
Q2 | $434K | Sell |
3,197
-12
| -0.4% | -$1.63K | 0.02% | 242 |
|
|
2023
Q1 | $333K | Hold |
3,209
| – | – | 0.01% | 262 |
|
|
2022
Q4 | $284K | Hold |
3,209
| – | – | 0.01% | 274 |
|
|
2022
Q3 | $257K | Hold |
3,209
| – | – | 0.01% | 273 |
|
|
2022
Q2 | $307K | Sell |
3,209
-16
| -0.5% | -$1.53K | 0.01% | 245 |
|
|
2022
Q1 | $479K | Hold |
3,225
| – | – | 0.02% | 207 |
|
|
2021
Q4 | $457K | Hold |
3,225
| – | – | 0.02% | 197 |
|
|
2021
Q3 | $422K | Hold |
3,225
| – | – | 0.02% | 197 |
|
|
2021
Q2 | $443K | Sell |
3,225
-11
| -0.3% | -$1.51K | 0.02% | 191 |
|
|
2021
Q1 | $423K | Hold |
3,236
| – | – | 0.02% | 184 |
|
|
2020
Q4 | $362K | Hold |
3,236
| – | – | 0.02% | 192 |
|
|
2020
Q3 | $255K | Hold |
3,236
| – | – | 0.01% | 221 |
|
|
2020
Q2 | $233K | Sell |
3,236
-30
| -0.9% | -$2.16K | 0.01% | 218 |
|
|
2020
Q1 | $187K | Buy |
3,266
+30
| +0.9% | +$1.72K | 0.01% | 232 |
|
|
2019
Q4 | $362K | Buy |
+3,236
| New | +$362K | 0.02% | 196 |
|